Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 1, 2006, Pages

  Bruce, Clinton R ^a,d   Thrush, A Brianne ^a   Mertz, Valerie A ^a   Bezaire, Veronic ^a   Chabowski, Adrian ^b   Heigenhauser, George J F ^c   Dyck, David J ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c MCMASTER UNIVERSITY   (Canada)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Ceramide; Diacylglycerol; Insulin resistance; Triacylglycerol

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CERAMIDE; DIACYLGLYCEROL; FATTY ACID; GLUCOSE; MALONYL COENZYME A; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FATTY ACID OXIDATION; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN TISSUE; MALE; MUSCLE BIOPSY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL STRESS; PRIORITY JOURNAL; TRAINING;

ADULT; AREA UNDER CURVE; BIOPSY, FINE-NEEDLE; BLOOD GLUCOSE; BLOTTING, WESTERN; CARNITINE O-PALMITOYLTRANSFERASE; CITRATE (SI)-SYNTHASE; ENOYL-COA HYDRATASE; EXERCISE; FATTY ACIDS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; MITOCHONDRIA, MUSCLE; MUSCLE, SKELETAL; OBESITY; TRIGLYCERIDES;

EID: 33745841299     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00587.2005     Document Type: Article

References (39)

1. Adams JM II, Pratipanawatr T, Berria R, Wang E, DeFronzo RA, Sullards MC, and Mandarino LJ. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53: 25-31, 2004.
2. Berthon PM, Howlett RA, Heigenhauser GJF, and Spriet LL. Human skeletal muscle carnitine palmitoyltransferase I activity determined in isolated intact mitochondria. J Appl Physiol 85: 148-153, 1998.
3. Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, and and Hawley JA. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J Clin Endocrinol Metab, 88: 5444-5451, 2003.
4. Bruce CR, Kriketos AD, Cooney GJ, and Hawley JA. Disassociation of muscle triglyceride content and insulin sensitivity after exercise training in patients with type 2 diabetes. Diabetologia 47: 23-30, 2004.
5. Bruce CR, Mertz VA, Heigenhauser GJ, and Dyck DJ. The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54: 3154-3160, 2005.
6. Cogswell AM, Stevens RJ, and Hood DA. Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am J Physiol Cell Physiol 264: C383-C389, 1993.
7. Cooney GJ, Thompson AL, Furler SM, Ye J, and Kraegen EW. Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207, 2002.
8. Dela F, Mikines KI, von Linstow M, Secher NH, and Galbo H. Effect of training on insulin-mediated glucose uptake in human muscle. Am J Physiol Endocrinol Metab 263: E1134-E1143, 1992.
9. Dobrzyń A and Górski J. Ceramides and sphingomyelins in skeletal muscles of the rat: content and composition: effect of prolonged exercise. Am J Physiol Endocrinol Metab 282: E277-E285, 2002.
10. Dobrzyn A, Zendzian-Piotrowska M, and Gorski J. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. J Physiol Pharmacol 55: 305-313, 2004.
11. Folch J, Lees M, and Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226: 497-509, 1957.
12. Gollnick PD and Saltin B. Significance of skeletal muscle oxidative enzyme enhancement with endurance training: hypothesis. Clin Physiol 2: 1-12, 1982.
13. Goodpaster BH, He J, Watkins S, and Kelley DE. Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 86: 5755-5761, 2001.
14. Helge JW and Dela F. Effect of training on muscle triacylglycerol and structural lipids: a relation to insulin sensitivity? Diabetes 52: 1881-1887, 2003.
15. Helge JW, Dobrzyn A, Saltin B, and Gorski J. Exercise and training effects on ceramide metabolism in human skeletal muscle. Exp Physiol 89: 119-127, 2004.
16. Holloszy JO and Coyle EF. Adaptations of skeletal muscle to endurance exercise and their metabolic consequences. J Appl Physiol 56: 831-838, 1984.
17. Horowitz JF, Leone TC, Feng W, Kelly DP, and Klein S. Effect of endurance training on lipid metabolism in women: a potential role for PPARα in the metabolic response to training. Am J Physiol Endocrinol Metab 279: E348-E355, 2000.
18. Houmard JA, Tanner CJ, Yu C, Cunningham PG, Pories WJ, MacDonald KG, and Shulman GI. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51: 2959-2963, 2002.
19. Hulver MW, Zheng D, Tanner CJ, Houmard JA, Kraus WE, Slentz CA, Sinha MK, Pories WJ, MacDonald KG, and Dohm GL. Adiponectin is not altered with exercise training despite enhanced insulin action. Am J Physiol Endocrinol Metab 283: E861-E865, 2002.
20. Itani SI, Ruderman NB, Schmieder F, and Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglyceol, protein kinase C, and IκB-α. Diabetes 51: 2005-2011, 2002.
21. Jong-Yeon K, Hickner RC, Dohm GL, and Houmard JA. Long- and medium-chain fatty acid oxidation is increased in exercise-trained human skeletal muscle. Metabolism 51: 460-464, 2002.
22. Kelley DE, Goodpaster B, Wing RR, and Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
23. Kim JY, Hickner RC, Cortright RL, Dohm GL, and Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab 279: E1039-E1044, 2000.
24. Kriketos AD, Gan SK, Poynten AM, Furler SM, Chisholm DJ, and Campbell LV. Exercise increases adiponectin levels and insulin sensitivity in humans. Diabetes Care 27:.629-630, 2004.
25. Lowry OH and Passonneau JV. A Flexible System of Enzymatic Analysis. New York: Academic, 1972.
26. Matsuda M and DeFronzo RA. Insulin sensitivity indices obtained from oral glucsoe tolerance testing. Diabetes Care 22: 1462-1470, 1999.
27. McGarry JD, Mills SE, Long CS, and Foster DW. Observations on the affinity for carnitine, and malonyl-CoA sensitivity, of carnitine palmitoyltransferase I in animal and human tissues. Demonstration of the presence of malonyl-CoA in non-hepatic tissues of the rat. Biochem J 214: 21-28, 1983.
28. Morrison WR and Smith LM. Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride-methanol. J Lipid Res 5: 600-608, 1964.
29. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
30. Perdomo G, Commerford SR, Richard AM, Adams SH, Corkey BE, O'Doherty RM, and Brown NF. Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J Biol Chem 279: 27177-27186, 2004.
31. Rimbert V, Boirie Y, Bedu M, Hocquette JF, Ritz P, and Morio B. Muscle fat oxidative capacity is not impaired by age but by physical inactivity: association with insulin sensitivity. FASEB J 18: 737-739, 2004.
32. Schmitz-Peiffer C, Browne CL, Oakes ND, Watkinson A, Chisholm DJ, Kraegen EW, and Biden TJ. Alterations in the expression and cellular localization of protein kinase C isoforms ε and θ are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178, 1997.
33. Schmitz-Peiffer C, Craig DL, and Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 274: 24202-24210, 1999.
34. Srere PA. Citrate synthase. Methods Enzymol 13: 3-11, 1969.
35. Starritt EC, Howlett RA, Heigenhauser GJF, and Spriet LL. Sensitivity of CPT I to malonyl-CoA in trained and untrained human skeletal muscle. Am J Physiol Endocrinol Metab 278: E462-E468, 2000.
36. Straczkowski M, Kowalska I, Nikolajuk A, Dzienis-Straczkowska S, Kinalska I, Baranowski M, Zendzian-Piotrowska M, Brzezinska Z, and Gorski J. Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 53: 1215-1221, 2004.
37. Summers SA, Garza L, Zhou H, and Birnbaum MJ. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 18: 5457-5464, 1998.
38. Tomas E, Tsao T-S, Saha AK, Murrey HE, Zhang C-C, Itani SI, Lodish HF, and Ruderman NB. Enhanced muscle fat oxidation and glucose transport by ACP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 99: 16309-16313, 2002.
39. Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, Bergeron R, Kim JK, Cushman SW, Cooney GJ, Atcheson B, White MF, Kraegen EW, and Shulman GI. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277: 50230-50236, 2002.